Additionally, the impaired cholinergic dilation of cerebral blood vessels in CHRM5‐knockout mice implies that M5 mAChR may play a role in the pathophysiology of Alzheimer's disease and focal cerebral ischemia [77]. Here, CHRM5 is linked to early-onset autosomal dominant Alzheimer disease.